Effects after starting or switching from bisphosphonate to romosozumab or denosumab in Japanese postmenopausal patients

PURPOSE: We aimed to investigate the longitudinal changes in bone metabolic markers and bone mineral density (BMD) after starting or switching from bisphosphonate (BP) to romosozumab (ROMO) or denosumab (DENO) therapies over 12 months and to determine predictors that establish associations with chan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Bone Miner Metab
Main Authors: Shimizu, Tomohiro, Arita, Kosuke, Murota, Eihiro, Hiratsuka, Shigeto, Fujita, Ryo, Ishizu, Hotaka, Asano, Tsuyoshi, Takahashi, Daisuke, Takahata, Masahiko, Iwasaki, Norimasa
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8042469/
https://ncbi.nlm.nih.gov/pubmed/33847831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00774-021-01226-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados